You Are Here: Home > Cancer Research > Drug Development >
CISN Summary of Drug Development Challenges

CISN Summary of
Drug Development Challenges

Drug development is a long, complicated and expensive endeavor. Each of the stakeholders has different and even sometimes-competing goals, so it is critically important that all aspects work as smoothly as possible.


Examination of the various parts of the process helps each of the stakeholders to better understand the other parts and to work as cooperatively as possible.

The major challenges of cancer drug development:
  • Length of time from early research to drug approval can be up to 20 years on average
  • The overall success rate for oncology products in clinical development is only about 10%
  • Cost to bring a new drug to market can reach approximately $1 billion
  • Resources are often invested in the development of compounds that ultimately are not viable treatments
  • Needs of multiple stakeholders are varied and sometimes conflicting
  • Multiple clinical trials must be conducted and many patient participants are needed for drug approval

Personalized Medicine
Recently Diagnosed
Cancer 101
Latina Navigator Training




You have reached the end of this section. If you wish to test your knowledge of
the subject matter, please visit: to take the corresponding e-Quiz -

"Drug Development"

For more information about our e-Training courses, please read the e-Quiz Introduction.



Site Design by: Cara M. Caloroso
CISN Home Page About Us Services CISN Home Page Contact Site Map CISN Home Page CISN Home Page